Quantitative expression analysis of metastasis-related ELAM-1 in nasopharyngeal carcinoma

被引:0
|
作者
Jin, Guanqiao [1 ]
Liu, Shuying [1 ]
Kang, Wei [1 ]
Huang, Miao [1 ]
Wang, Duoping [2 ]
Qu, Song [3 ]
Liao, Zhiling [4 ]
Su, Danke [1 ]
机构
[1] Guangxi Med Univ, Affiliated Tumor Hosp, Radiat Dept, Nanning, Peoples R China
[2] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Head & Neck Surg, Nanning, Peoples R China
[3] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Ultrasound, Nanning, Peoples R China
[4] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Pathol, Nanning, Peoples R China
基金
中国国家自然科学基金;
关键词
Nasopharyngeal carcinoma; ELAM-1; metastasis; E-SELECTIN; CONCOMITANT RADIOTHERAPY; DISTANT METASTASIS; PROGNOSTIC-FACTORS; TUMOR-CELLS; CANCER; CHEMOTHERAPY; ADHESION; ICAM-1; CHINA;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To investigate the expression of metastasis- related endothelial leukocyte adhesion molecules-1 (EMLA-1) in patients with nasopharyngeal carcinoma (NPC). Methods: Cancer tissue specimens were obtained nasopharyngeal biopsy of 46 patients with NPC. The quantitative expression of metastasis-related ELAM-1 in all patients was performed using immunohistochemical SP method. These patients were divided into metastasis group and non-metastasis group according to medical imaging examination. The quantitative expression of metastasis related ELAM-1 was analyzed in different groups and clinic-pathologic features. Results: 93.1% (27/29) positive expression of ELAM-1 in 29 metastatic patients was higher that of 17 non-metastasis (23.5%, 4/17), there was significant different in the positive expression of ELAM-1 between two groups (x(2)=23.607, P=0.000), and there was a positive correlation between ELAM-1 expression and metastasis (r=0.571, P=0.000), but there were no relationship between ELAM-1 expression and clinical staging, T staging, age and gender (P>0.05). Conclusion: Over-expression of ELAM-1 may contribute to metastatic spread, and will serve as a potential prognostic biomarker in patients with NPC.
引用
收藏
页码:808 / 813
页数:6
相关论文
共 50 条
  • [1] IRIS ELAM-1 EXPRESSION IN CLINICALLY QUIESCENT UVEITIS
    NI, M
    BLOOM, JN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 843 - 843
  • [2] Brimomiline induces the expression of ELAM-1 in TM cells
    Diskin, S
    Wang, N
    Fini, ME
    Schuman, JS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1171 - U1171
  • [3] ELFT - A GENE THAT DIRECTS THE EXPRESSION OF AN ELAM-1 LIGAND
    GOELZ, SE
    HESSION, C
    GOFF, D
    GRIFFITHS, B
    TIZARD, R
    NEWMAN, B
    CHIROSSO, G
    LOBB, R
    CELL, 1990, 63 (06) : 1349 - 1356
  • [5] Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinoma
    Song, Pei-Ming
    Zhang, Yang
    He, Yu-Fei
    Bao, Hui-Min
    Luo, Jian-Hua
    Liu, Yin-Kun
    Yang, Peng-Yuan
    Chen, Xian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (38) : 5816 - 5822
  • [6] ELAM-1 EXPRESSION AFTER CALCITRIOL AND UVB TREATMENT OF PSORIASIS
    CHEN, RZ
    ZHENG, ZS
    PRYSTOWSKY, JH
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (04) : 671 - 671
  • [7] Different expression of metastasis-related genes in primary and metastatic colorectal carcinoma
    Choi, J.
    Koh, K.
    Kim, H.
    HISTOPATHOLOGY, 2008, 53 : 298 - 298
  • [8] Relationship between serum ELAM-1 and metastasis among patients with colon cancer
    Takahashi, Y
    Mai, M
    Watanabe, M
    Tokiwa, M
    Nishioka, K
    DISEASES OF THE COLON & RECTUM, 1998, 41 (06) : 770 - 774
  • [9] Enhanced expression of ELAM-1 on endothelium of renal cell carcinoma compared to the corresponding normal renal tissue
    Brenner, W
    Hempel, G
    Steinbach, F
    Hohenfellner, R
    Thüroff, JW
    CANCER LETTERS, 1999, 143 (01) : 15 - 21
  • [10] Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma
    Gao, Yunzhen
    Chen, Geng
    Zeng, Yongyi
    Zeng, Jinhua
    Lin, Minjie
    Liu, Xiaolong
    Liu, Jingfeng
    TUMOR BIOLOGY, 2015, 36 (10) : 7409 - 7422